The Endocrine Society praised the European Food Safety Agency’s (EFSA) decision to establish a strict limit on the amount of bisphenol A (BPA) that can be safely consumed daily.
BPA — a chemical that mimics the effects of estrogen on the body — seeps into food and drinks through plastics and other packaging. BPA has been linked to infertility, obesity, heart disease, type 2 diabetes, cancer and neurodevelopmental issues such as attention deficit/hyperactivity disorder.
Because of widespread use of BPA in consumer products and other goods, people of all ages consume at least 150 times more than the new tolerable daily intake (TDI) of 0.2 ng of BPA per kilogram of body weight, on average, according to EFSA. Infants between the ages of six and 12 months and toddlers between the ages of one and three years old consume, on average, more than 4,200 times the tolerable daily intake.
“The revised tolerable daily intake reflects a large foundation of scientific information demonstrating that even exposure to extremely low levels of BPA can cause a variety of harmful effects, including on endocrine systems,” says Endocrine Society spokesperson Anne Simone Parent, MD, PhD, of the University of Liège in Liège, Belgium. “As researchers studying the impact of BPA and other chemicals on the body’s hormones, we are encouraged to see EFSA recognize the need for aggressive action to limit our exposure and protect public health.”
Diet is the primary source of BPA exposure for most people. People also can be exposed to BPA through other sources. Air, dust and water are potential sources of exposure.
While in a previous draft opinion EFSA proposed a slightly lower tolerable daily intake of 0.04 ng of BPA per kilogram of body weight, the final TDI sends a strong message to regulators that urgent action is needed to protect the public from exposure.
Research indicates exposure to BPA and other endocrine-disrupting chemicals resulted in more than €157 billion a year in health care costs and lost wages.
You may also like
2025 Researchers Roundtable: Discussing Endocrine Science with the 2025 Early Investigator Award Winners
Every year the Endocrine Society recognizes endocrinologists who are in the early stages of their research careers with the Early Investigator Awards. Endocrine News spoke to the five award recipients from around the world to find out more about their award-winning research, the award’s potential impact, as well as the biggest challenges facing them today….
Hoshino Wins Wayne Bardin International Travel Award
The Endocrine Society has selected Yoshitomo Hoshino, MD, PhD, as the recipient of its 2025 C. Wayne Bardin, MD, International Travel Award for his outstanding ENDO abstract and research contributions to the care of patients with bone health disorders. The C. Wayne Bardin, MD, International Travel Award was created in honor of Past President Wayne…
